References
- Azziz R. Definition, diagnosis, and epidemiology of the polycystic ovary syndrome. In: Azziz R, ed. The polycystic ovary syndrome: current concepts on pathogenesis and clinical care. New York (NY): Springer, 2007:ch 1:1–15
- Goodarzi MO, Dumesic DA, Chazenbalk G, et al. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011;7:219–31
- Ayaz A, Alwan Y, Farooq MU. Efficacy of combined metformin-clomiphene citrate in comparison with clomiphene citrate alone in infertile women with polycystic ovarian syndrome (PCOS). J Med Life 2013;6:199–201
- Nestler JE, Jakubowicz DJ, Evans WS, et al. Effects of metformin on spontaneous and clomiphene-induced ovulation in the P.C.O.S. N Engl J Med 1998;338:1876–80
- Sekhon B, Sekhon C, Khan M, et al. N-acetyl cysteine protects against injury in a rat model of focal cerebral ischemia. Brain Res 2003;971:1–8
- Lappas M, Permezel M, Rice GE. N-acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-kappaB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J Clin Endocrinol Metab 2003;88:1723–9
- The Rotterdam ESHRE/ASRA-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Bart C.J.M. Fauser, Center of Reproductive Medicine, Erasmus Medical Center, 3015 GD Rotterdam, Netherlands. Hum Reprod 2004;19:41–7
- Badawy A, State O, Abdelgawad S. N-acetyl cysteine and clomiphene citrate for induction of ovulation in polycystic ovary syndrome: a cross-over trial. Acta Obstet Gynecol Scand 2007;86:218–22
- Wentzel P, Thunberg L, Eriksson UJ. Teratogenic effect of diabetic serum is prevented by supplementation of superoxide dismutase and N-acetyl cysteine in rat embryo culture. Diabetologia 1997;40:7–14
- Palomba S, Orio F Jr, Falbo A, et al. Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J Clin Endoc Metab 2005;90:4068–74
- Moghetti P, Castello R, Negri C, et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 2000;85:139–46
- Saghar S, Azadeh AS, Nasrin S, et al. N-acetylcysteine as an adjuvant to clomiphene citrate for successful induction of ovulation in infertile patients with polycystic ovary syndrome. J Obstet Gynaecol Res 2012;38:1182–6
- Rizk AY, Bedaiwy MA, Al-Inany HG. N-acetyl-cysteine is a novel adjuvant to clomiphene citrate in clomiphene citrate resistant patients with polycystic ovary syndrome. Fertil Steril 2005;83:367–70
- Thakker D, Raval A, Patel I, et al. N-acetylcysteine for polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled clinical trials. Obstet Gynecol Int 2015;2015:817849. doi:10.1155/2015/817849